RESULT OF RIKSBANK CERTIFICATE SALE
| Auction | Auction results |
| Auction date | 2022-07-19 |
| Start date | 2022-07-20 |
| Maturity date | 2022-07-27 |
| Interest rate | 0.75 % |
| Offered volume, SEK bn | 561.0 |
| Total bid amount, SEK bn | 2826.3 |
| Accepted volume, SEK bn | 561.0 |
| Number of bids | 16 |
| Percentage allotted, % | 19.849 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Resultat af den ordinære generalforsamling 202418.4.2024 17:07:01 CEST | pressemeddelelse
SELSKABSMEDDELELSE Odense, 18. april 2024 Selskabsmeddelelse nr. 49 – 18.04.24 Resultat af den ordinære generalforsamling 2024 Danish Aerospace Company A/S CVR nr.: 12 42 42 48 Torsdag den 18. april 2024 afholdtes ordinær generalforsamling i Danish Aerospace Company A/S. Dagsordenen var følgende: 1. Valg af dirigent 2. Bestyrelsens beretning om selskabets virksomhed i det forgangne regnskabsår 3. Forelæggelse af årsrapport med revisionspåtegning til godkendelse 4. Beslutning om anvendelse af overskud eller dækning af underskud i henhold til den godkendte årsrapport. 5. Bemyndigelse til at forhøje selskabskapitalen 6. Bemyndigelse til at udstede aktietegningsretter 7. Valg af medlemmer til bestyrelsen, herunder formand og næstformand. 1.1 Valg af formand 1.2 Valg af næstformand 1.3 Valg af øvrige medlemmer af bestyrelsen 8. Valg af revisor 9. Forslag fra bestyrelsen eller aktionærerne 9.1 Ny §3.5 i vedtægterne om mulighed for at afholde generalforsamlinger som delvis eller fuld elektron
Results of annual general meeting 202418.4.2024 17:07:01 CEST | Press release
COMPANY ANNOUNCEMENT Odense, April 18th, 2024 Company Announcement no. 49 – 18.04.2024 Results of annual general meeting 2024 Danish Aerospace Company A/S CVR no.: 12 42 42 48 On Thursday April 18th, 2024, the annual general meeting of Danish Aerospace Company A/S was held. The agenda was as follows: 1. Election of chairperson for the Annual Meeting. 2. The Board of Directors’ report on the company’s activities in the past financial year. 3. Presentation of the 2023 Annual Report including auditor’s report for approval. 4. Decision on use of profit or coverage of deficit in regard to the approved annual report. 5. Authorization to increase the company’s share capital. 6. Authorization to issue warrants. 7. Election of members for the Board of Directors, including chairman and deputy chairman. 1.1 Election of chairman. 1.2 Election of deputy chairman. 1.3 Election of remaining members of the board. 8. Election of auditor. 9. Proposals from the Board of Directors or shareholders. 9.1 New
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates18.4.2024 17:00:00 CEST | Press release
l Qassimi Hospital Sharjah becomes first in the Middle East to treat patients with innovative new device-based option to help reduce blood pressure. Palo Alto, CA, April 18, 2024 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), announce the first commercial uses of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension in the United Arab Emirates (UAE). Three cases were performed at Al Qassimi Hospital in Sharjah by Dr. Arif Al Nooryani and Dr. Loai Mousa as second operator. The Paradise uRDN system is a first-of-its-kind ultrasound-based renal denervation (RDN) technology designed to lower blood pressure by denervating overactive sympathetic nerves surrounding the renal arteries. Paradise uRDN delivers two to three doses of 360-degree ultrasound energy — lasting seven seconds each — through the main renal arteries to the surrounding nerves. The Paradise cathete
Q1, 202418.4.2024 16:56:35 CEST | Press release
To Nasdaq OMX Copenhagen A/S Public announcement no. 556 April 18th, 2024 ECONOMIC KEY FIGURES FOR GLUNZ & JENSEN HOLDING A/S Q1 2024 The Q1, 2024 (January through March 2024) of the fiscal year was reviewed and approved by the Board of Directors. The Board of Directors announces the following consolidated financial statement year to date (YTD) for Q1 (January through March) of 2024. Highlights for the Q1 result for the fiscal year 2024: The revenue for YTD Q1, 2024 amounted to DKK 31.1 million (2023: DKK 40.5 million). EBITDA for the period was DKK 2.6 million (2023: DKK 6.4 million). Profit before tax for the period was DKK 1.0 million (2023: DKK 4.9 million). In the previous year (2023), Glunz & Jensen delivered a particularly strong Q1. Overall, the Q1, 2024 came out with better-than-expected revenue figures in the offset and flexo solvent segments, whereas the thermal segment showed a week demand. For further information please contact: CEO Henrik Blegvad Funk: phone +45 21 39 05
CONSTITUENT MEETING OF HONKARAKENNE'S BOARD OF DIRECTORS AND COMMITEES18.4.2024 16:45:00 CEST | Press release
HONKARAKENNE OYJ Stock Exchange Release 18 April 2024 at 17:45 CONSTITUENT MEETING OF HONKARAKENNE’S BOARD OF DIRECTORS AND COMMITTEES Honkarakenne Oyj’s Annual General Meeting held on Thursday 18 April 2024 in Honkarakenne’s Tuusula office at Lahdentie 870, Tuusula, Finland. The Annual General Meeting elected the following persons to the Board of Directors: Arto Halonen, Timo Kohtamäki, Maria Ristola, Kari Saarelainen and Antti Tiitola. The Board of Directors convened for its constituent meeting and appointed Timo Kohtamäki as Chairman of the Board and Maria Ristola as Vice Chairman of the Board. At the same board meeting Board of Directors decided not to set up any committees. HONKARAKENNE OYJ Marko Saarelainen President and CEO Further information: Marko Saarelainen, President and CEO, tel. +358 40 542 0254, marko.saarelainen@honka.com or Maarit Jylhä, CFO, tel. +358 40 594 4099, Maarit.jylha@honka.com DISTRIBUTION Nasdaq Helsinki Ltd Key media Financial Supervisory Authority www.ho